PVLA and 0ACX Related Headlines
Go Back- Palvella plans March 2026 data readout for rare skin disease drug
- Palvella Therapeutics Provides Corporate Update and 2026 Outlook: Advancing a Late Clinical-Stage Pipeline and Platform to Address Multiple Serious, Rare Skin Diseases and Vascular Malformations with
